Pivotal bioVenture raises the stakes in biotech and pharmaceutical support
The latest $389m pledge follows an initial investment of $300m in 2017 that was raised to fund early-stage life-science startups.
The latest $389m pledge follows an initial investment of $300m in 2017 that was raised to fund early-stage life-science startups.
What's Your Reaction?
